From June 6 to 8, 2025, the highly anticipated China Gut Microbiome Conference was grandly held in Ningbo. As a major academic event in the field of gut microbiome research, the conference brought together top experts and enterprises from both domestic and international arenas to discuss the future directions of microbiome research innovation and clinical application development.
As a professional enterprise in germ-free animal technology and microbiome research services, Gnotobio Biotechnology was invited to exhibit and deliver a special presentation at the conference, comprehensively showcasing the company's technological achievements and practical experience in disease research platform development and scientific research services.
Gnotobio Biotechnology showcased its core products and service solutions at the event, including:
● Customized Germ-Free Animal Research Services
● Microbial Colonization and Microbiota Intervention Solutions
● Intestine-Related Chronic Disease Model Systems
In recognition of its outstanding performance in scientific research support and service innovation, Gnotobio Biotechnology was honored at the conference with the title of "Enterprise with Outstanding Strength in Research & Development Services". This award is a strong affirmation of Gnotobio's long-term commitment to深耕 (deeply cultivating) the fields of microbiome and animal model services, as well as its dedication to empowering scientific research and innovation.
Looking ahead, Gnotobio Biotechnology will continue to drive the integrated development of germ-free animal models and microbiome research, providing research institutions, medical organizations, and corporate clients with higher-quality technology platforms and one-stop solutions, and offering high-standard technical support for gut health research in China.